Skip to content

Relay Therapeutics, Inc. RLAY Increase Decrease In Operating Lease Assets And Liabilities Net

Increase Decrease In Operating Lease Assets And Liabilities Net at other companies

EPR Properties logo
EPR PropertiesEPR
-$520K-77.5%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-$1.52M-32.1%
UCT
Ultra Clean HoldingsUCTT
-$400K+71.4%
Erasca, Inc. logo
Erasca, Inc.ERAS
$421K+9.4%
Open Text logo
Open TextOTEX
$4.8M+29.8%
WD-40 Company logo
WD-40 CompanyWDFC
$238K+1,800%

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept rlay:IncreaseDecreaseInOperatingLeaseAssetsAndLiabilitiesNet.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s increase decrease in operating lease assets and liabilities net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s increase decrease in operating lease assets and liabilities net?
Relay Therapeutics, Inc. (RLAY) reported increase decrease in operating lease assets and liabilities net of -$506K in Q1 2026.
How has Relay Therapeutics, Inc.'s increase decrease in operating lease assets and liabilities net changed year-over-year?
Relay Therapeutics, Inc.'s increase decrease in operating lease assets and liabilities net decreased by 78.8% year-over-year, from -$283K to -$506K.
What is the long-term trend for Relay Therapeutics, Inc.'s increase decrease in operating lease assets and liabilities net?
Over 3 years (2021 to 2024), Relay Therapeutics, Inc.'s increase decrease in operating lease assets and liabilities net has grown at a 64.9% compound annual growth rate (CAGR), from -$277K to -$1.24M.
What does increase decrease in operating lease assets and liabilities net mean?
Represents the net change in the balance sheet accounts associated with operating leases, including the right-of-use asset and corresponding lease liabilities. This adjustment accounts for the difference between cash lease payments and the straight-line lease expense recognized in the income statement. It is essential for understanding the cash impact of long-term lease commitments.